ALT
Price
$3.27
Change
-$0.02 (-0.61%)
Updated
Sep 11 closing price
Capitalization
634.52M
59 days until earnings call
Intraday BUY SELL Signals
OGEN
Price
$0.48
Change
-$0.02 (-4.00%)
Updated
Sep 11 closing price
Capitalization
2.16M
Intraday BUY SELL Signals
Interact to see
Advertisement

ALT vs OGEN

ALT vs OGEN Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ALT vs. OGEN commentary
Sep 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALT is a Buy and OGEN is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALT($635M) has a higher market cap than OGEN($2.16M). ALT YTD gains are higher at: -9.418 vs. OGEN (-38.968). OGEN has higher annual earnings (EBITDA): -10.27M vs. ALT (-88.13M). ALT has more cash in the bank: 326M vs. OGEN (3.86M). OGEN has less debt than ALT: OGEN (56.1K) vs ALT (36M). ALT has higher revenues than OGEN: ALT (31K) vs OGEN (0).
ALTOGENALT / OGEN
Capitalization635M2.16M29,439%
EBITDA-88.13M-10.27M858%
Gain YTD-9.418-38.96824%
P/E RatioN/A0.49-
Revenue31K0-
Total Cash326M3.86M8,437%
Total Debt36M56.1K64,171%
FUNDAMENTALS RATINGS
ALT vs OGEN: Fundamental Ratings
ALT
OGEN
OUTLOOK RATING
1..100
815
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
28
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
96100
PRICE GROWTH RATING
1..100
4582
P/E GROWTH RATING
1..100
1002
SEASONALITY SCORE
1..100
19n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

OGEN's Valuation (28) in the Biotechnology industry is somewhat better than the same rating for ALT (93) in the Miscellaneous Commercial Services industry. This means that OGEN’s stock grew somewhat faster than ALT’s over the last 12 months.

OGEN's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as ALT (100) in the Miscellaneous Commercial Services industry. This means that OGEN’s stock grew similarly to ALT’s over the last 12 months.

ALT's SMR Rating (96) in the Miscellaneous Commercial Services industry is in the same range as OGEN (100) in the Biotechnology industry. This means that ALT’s stock grew similarly to OGEN’s over the last 12 months.

ALT's Price Growth Rating (45) in the Miscellaneous Commercial Services industry is somewhat better than the same rating for OGEN (82) in the Biotechnology industry. This means that ALT’s stock grew somewhat faster than OGEN’s over the last 12 months.

OGEN's P/E Growth Rating (2) in the Biotechnology industry is significantly better than the same rating for ALT (100) in the Miscellaneous Commercial Services industry. This means that OGEN’s stock grew significantly faster than ALT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALTOGEN
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
N/A
Bullish Trend 5 days ago
79%
Declines
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
76%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
COMPARISON
Comparison
Sep 12, 2026
Stock price -- (ALT: $3.27 vs. OGEN: $0.48)
Brand notoriety: ALT and OGEN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALT: 64% vs. OGEN: 234%
Market capitalization -- ALT: $634.52M vs. OGEN: $2.16M
ALT [@Biotechnology] is valued at $634.52M. OGEN’s [@Biotechnology] market capitalization is $2.16M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $130.64B. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALT’s FA Score shows that 0 FA rating(s) are green while OGEN’s FA Score has 2 green FA rating(s).

  • ALT’s FA Score: 0 green, 5 red.
  • OGEN’s FA Score: 2 green, 3 red.
According to our system of comparison, OGEN is a better buy in the long-term than ALT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALT’s TA Score shows that 4 TA indicator(s) are bullish while OGEN’s TA Score has 3 bullish TA indicator(s).

  • ALT’s TA Score: 4 bullish, 3 bearish.
  • OGEN’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, ALT is a better buy in the short-term than OGEN.

Price Growth

ALT (@Biotechnology) experienced а -4.39% price change this week, while OGEN (@Biotechnology) price change was -6.27% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.09%. For the same industry, the average monthly price growth was -3.45%, and the average quarterly price growth was +2531.70%.

Reported Earning Dates

ALT is expected to report earnings on Nov 10, 2026.

Industries' Descriptions

@Biotechnology (-6.09% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
ALT
Daily Signal:
Gain/Loss:
OGEN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
YUMC42.320.03
+0.07%
Yum China Holdings
FSEA17.17-0.02
-0.12%
First Seacoast Bancorp
YHC1.41-0.02
-1.40%
LQR House Inc.
BKV24.23-0.73
-2.92%
BKV Corp
ENRD3.66-0.34
-8.50%
EINRIDE AB ADS

ALT and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALT has been loosely correlated with OGEN. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if ALT jumps, then OGEN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALT
1D Price
Change %
ALT100%
-0.61%
OGEN - ALT
54%
Loosely correlated
-5.03%
ACHV - ALT
45%
Loosely correlated
-3.02%
INDP - ALT
45%
Loosely correlated
+8.20%
RXRX - ALT
42%
Loosely correlated
+1.27%
BCYC - ALT
42%
Loosely correlated
+0.78%
More

OGEN and

Correlation & Price change

A.I.dvisor indicates that over the last year, OGEN has been loosely correlated with UNCY. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if OGEN jumps, then UNCY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OGEN
1D Price
Change %
OGEN100%
-5.03%
UNCY - OGEN
34%
Loosely correlated
-0.38%
MGX - OGEN
33%
Loosely correlated
N/A
GOVX - OGEN
32%
Poorly correlated
-0.54%
SRPT - OGEN
30%
Poorly correlated
-0.34%
ALZN - OGEN
29%
Poorly correlated
+1.18%
More